36160-84-6 Usage
General Description
2-CHLORO-N-(4-PHENOXYPHENYL)ACETAMIDE, also known as clofibric acid, is a chemical compound used as a lipid-lowering agent and as a treatment for hyperlipidemia. It belongs to the class of fibric acid derivatives and is structurally related to the drug clofibrate. It works by increasing the breakdown of triglycerides and decreasing the production of LDL cholesterol in the liver, ultimately reducing the risk of cardiovascular diseases. However, it has been found to have potential toxic effects on the liver and kidneys in some individuals, and its use is now limited in favor of safer and more efficacious lipid-lowering agents. Due to its potential for side effects, its use as a pharmaceutical agent has declined, and it is mainly used as a research tool in studying lipid metabolism and related diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 36160-84-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,1,6 and 0 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 36160-84:
(7*3)+(6*6)+(5*1)+(4*6)+(3*0)+(2*8)+(1*4)=106
106 % 10 = 6
So 36160-84-6 is a valid CAS Registry Number.
InChI:InChI=1/C14H12ClNO2/c15-10-14(17)16-11-6-8-13(9-7-11)18-12-4-2-1-3-5-12/h1-9H,10H2,(H,16,17)
36160-84-6Relevant articles and documents
Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential
Aguilera, Renato J.,Choe, Jun-yong,Hess, Jessica D.,Iancu, Cristina V.,Macias, Lucasantiago Henze,Meyer-Almes, Franz-Josef,Mrowka, Piotr,Ramaa, C. S.,Tilekar, Kalpana,Upadhyay, Neha
, (2020/07/07)
Cancer cells increase their glucose uptake and glycolytic activity to meet the high energy requirements of proliferation. Glucose transporters (GLUTs), which facilitate the transport of glucose and related hexoses across the cell membrane, play a vital ro
COMPOSITONS AND METHODS FOR MODULATING UBA5
-
Paragraph 0633; 0635; 0638; 0646, (2018/08/26)
Disclosed herein, inter alia, are compositions and methods useful for inhibiting ubiquitin-like modifier activating enzyme 5.
COMPOSITIONS AND METHODS FOR INHIBITING RETICULON 4
-
Paragraph 0646; 0649, (2018/08/26)
Disclosed herein, inter alia, are compositions and methods useful for inhibiting reticulon 4(RTN4).